Activation of 11β-hydroxysteroid dehydrogenase by dehydroepiandrosterone sulphate as an anti-hypertensive agent in spontaneously hypertensive rats

被引:16
作者
Homma, M
Onodera, T
Hirabatake, M
Oka, K
Kanazawa, M
Miwa, T
Hayashi, T
机构
[1] Tokyo Univ Pharm & Life Sci, Dept Clin Pharmacol, Hachioji, Tokyo 19203, Japan
[2] Tokyo Med Coll, Dept Internal Med 3, Shinjuku Ku, Tokyo 1600023, Japan
关键词
D O I
10.1111/j.2042-7158.1998.tb03325.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The anti-hypertensive properties of dehydroepiandrosterone sulphate (DHEAS) have been investigated by studying its effects on blood pressure, on serum concentrations of corticosterone and dehydrocorticosterone, and on 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD) activity in spontaneously hypertensive rats (SHR). SHR were given intraperitoneal injections of DHEAS (10 mg day(-1) for 70 days) from six to 16 weeks of age. The blood pressure-time curve was significantly (P < 0.05) suppressed immediately after administration of DHEAS. There was no difference between the heart rates of control and DHEAS groups. Serum concentrations of corticosterone and dehydrocorticosterone in the DHEAS group were significantly (P < 0.05) lower than those of the control group. The dehydrocorticosterone/corticosterone concentration ratio was, however, significantly (P < 0.05) higher in the DHEAS group, suggesting that treatment with DHEAS enhanced the overall interconversion of corticosterone to dehydrocorticosterone. The activity of 11 beta-HSD in specific organs of the DHEAS group was affected, characteristic changes being increases in the kidney (14-58%), decreases in the liver (11-27%) and no change in the testis. Direct addition of DHEAS to I 11 beta-HSD preparations from the kidneys of control SHR had the same effect as that observed in the in-vivo experiments. The fall in serum corticosterone in the DHEAS group is considered to be related, at least partly, to increased activity of kidney 11 beta-HSD. The inverse correlation of kidney 11 beta-HSD activity with serum corticosterone and blood pressure (-r = 0.628, P < 0.01, and -r = 0.478, P < 0.05, respectively) suggest that DHEAS delayed the development of hypertension in SHR by selective promotion of kidney 11 beta-HSD activity which in turn resulted in lower serum concentrations of corticosterone and its minimal aldosterone-like activity.
引用
收藏
页码:1139 / 1145
页数:7
相关论文
共 24 条
[1]   Dehydroepiandrosterone (DHEA): A fountain of youth? [J].
Baulieu, EE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (09) :3147-3151
[2]   DISPARATE EFFECTS OF INSULIN REDUCTION WITH DILTIAZEM ON SERUM DEHYDROEPIANDROSTERONE-SULFATE LEVELS IN OBESE HYPERTENSIVE MEN AND WOMEN [J].
BEER, NA ;
JAKUBOWICZ, DA ;
BEER, RM ;
NESTLER, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (04) :1077-1081
[3]   THE CALCIUM-CHANNEL BLOCKER AMLODIPINE RAISES SERUM DEHYDROEPIANDROSTERONE SULFATE AND ANDROSTENEDIONE, BUT LOWERS SERUM CORTISOL, IN INSULIN-RESISTANT OBESE AND HYPERTENSIVE MEN [J].
BEER, NA ;
JAKUBOWICZ, DJ ;
BEER, RM ;
NESTLER, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (06) :1464-1469
[4]  
CONNOR EB, 1986, NEW ENGL J MED, V315, P1519
[5]   ALTERATIONS IN CORTISOL METABOLISM IN INSULIN-DEPENDENT DIABETES-MELLITUS - RELATIONSHIP WITH METABOLIC CONTROL AND ESTIMATED BLOOD-VOLUME AND EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION [J].
DULLAART, RPF ;
UBELS, FL ;
HOOGENBERG, K ;
SMIT, AJ ;
PRATT, JJ ;
MUNTINGA, JHJ ;
SLUITER, WJ ;
WOLTHERS, BG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (10) :3002-3008
[6]   LOCALIZATION OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTOR [J].
EDWARDS, CRW ;
BURT, D ;
MCINTYRE, MA ;
DEKLOET, ER ;
STEWART, PM ;
BRETT, L ;
SUTANTO, WS ;
MONDER, C .
LANCET, 1988, 2 (8618) :986-989
[7]   MINERALOCORTICOID ACTION - TARGET TISSUE-SPECIFICITY IS ENZYME, NOT RECEPTOR, MEDIATED [J].
FUNDER, JW ;
PEARCE, PT ;
SMITH, R ;
SMITH, AI .
SCIENCE, 1988, 242 (4878) :583-585
[8]   ABNORMALITIES IN THE HYPOTHALAMO-PITUITARY-ADRENAL AXIS IN SPONTANEOUSLY HYPERTENSIVE RATS DURING DEVELOPMENT OF HYPERTENSION [J].
HASHIMOTO, K ;
MAKINO, S ;
HIRASAWA, R ;
TAKAO, T ;
SUGAWARA, M ;
MURAKAMI, K ;
ONO, K ;
OTA, Z .
ENDOCRINOLOGY, 1989, 125 (03) :1161-1167
[9]   COMPARISON OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE IN SPONTANEOUSLY HYPERTENSIVE AND WISTAR-KYOTO RATS [J].
HERMANS, JJR ;
STECKEL, B ;
THIJSSEN, HHW ;
JANSSEN, BJA ;
NETTER, KJ ;
MASER, E .
STEROIDS, 1995, 60 (11) :773-779
[10]   A NOVEL 11-BETA-HYDROXYSTEROID DEHYDROGENASE INHIBITOR CONTAINED IN SAIBOKU-TO, A HERBAL REMEDY FOR STEROID-DEPENDENT BRONCHIAL-ASTHMA [J].
HOMMA, M ;
OKA, K ;
NIITSUMA, T ;
ITOH, H .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1994, 46 (04) :305-309